✦ LIBER ✦

Clinical hallmarks and epidemiology of stiff person syndrome in Tanzania

✍ Scribed by Dekker, M.; Urasa, S.; Maro, V.; Kinabo, G.; Howlett, W.

Book ID: 122419338
Publisher: Elsevier Science
Year: 2013
Tongue: English
Weight: 64 KB
Volume: 333
Category: Article
ISSN: 0022-510X
DOI: 10.1016/j.jns.2013.07.397

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Quality of life in stiff person syndrome

✍ Willibald Gerschlager; Anette Schrag; Peter Brown 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 75 KB

## Abstract Stiff person syndrome (SPS) is a rare, chronic disorder characterized by painful spasm and stiffness. We investigated the quality of life (QoL) in SPS patients, and identified factors associated with impairment in patients' QoL. Twenty‐four SPS patients (10 men, 14 women; mean age ± S.D

Efficacy of pregabalin in a case of stif

Efficacy of pregabalin in a case of stiff-person syndrome: Clinical and neurophysiological evidence

✍ G. Squintani; T. Bovi; L. Ferigo; A.M. Musso; S. Ottaviani; G. Moretto; F. Morga 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 251 KB

Progress and stiff challenges in underst

Progress and stiff challenges in understanding the role of GAD-antibodies in stiff-person syndrome

✍ Dalakas, Marinos C. 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 424 KB

PET evidence of central GABAergic change

PET evidence of central GABAergic changes in stiff-person syndrome

✍ Daniela Perani; Valentina Garibotto; Andrea Panzacchi; Rosa Maria Moresco; Paola 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 80 KB

## Abstract We measured expression of central nervous system GABA‐A receptors with ^11^C‐flumazenil (^11^C‐FMZ) and PET in two subjects with stiff person syndrome (SPS). We found reduced ^11^C‐FMZ binding potential (BP) in motor‐premotor cortex, and increased ^11^C‐FMZ BP in the cerebellar nuclei.

A therapeutic trial of milacemide in myo

A therapeutic trial of milacemide in myoclonus and the stiff-person syndrome

✍ P. Brown; P. D. Thompson; J. C. Rothwell; B. L. Day; Prof. C. D. Marsden 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 269 KB 👁 1 views

We investigated the therapeutic effects of milacemide in seven patients with myoclonus and three patients with the stiff-person syndrome in an open-label trial. Milacemide was initiated at 800 mg/day and was gradually increased to a maximum dosage of 2,400 mg/day. No significant improvement occurred

Guillain-Barré syndrome in northern Tanz

Guillain-Barré syndrome in northern Tanzania: a comparison of epidemiological and clinical findings with western Norway

✍ W. P. Howlett; C. A. Vedeler; H. Nyland; J. A. Aarli 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 623 KB